Filana Therapeutics, Inc.

FLNA chart

Filana Therapeutics, Inc. news

• Filana Therapeutics, Inc. Estimates – HAM:PX91

  TradingView · Oct 23, 7:02 PM EDT

• Fifth Circuit Vacates Class Certification in Filana Therapeutics Securities Case

  The Clinical Trial Vanguard · Oct 22, 2:48 AM EDT

• Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

  Yahoo Finance · Oct 9, 8:00 AM EDT

• Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

  Yahoo Finance · Sep 22, 8:00 AM EDT

• Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

  Yahoo Finance · Jul 29, 8:00 AM EDT

• Data I/O And 2 Other Promising Penny Stocks To Watch

  Yahoo Finance · May 29, 2:05 PM EDT

• Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

  Yahoo Finance · May 7, 8:00 AM EDT

• Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

  Yahoo Finance · May 5, 8:00 AM EDT

• Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data

  Yahoo Finance · Apr 15, 8:00 AM EDT

Filana Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-KFORM 8-K2026-10-20
• 8-KFORM 8-K2026-09-22
• 8-KFORM 8-K2026-09-18
• 10-QFORM 10-Q2026-07-29
• 8-KFORM 8-K2026-07-29
• 8-KFORM 8-K2026-06-15
• 10-QFORM 10-Q2026-05-07
• 8-KFORM 8-K2026-05-07
• DEF 14AFORM DEF 14A2026-04-28
• 8-KFORM 8-K2026-04-28
• 10-KFORM 10-K2026-03-12
• 8-KFORM 8-K2026-03-12

About Filana Therapeutics, Inc.

Ticker

FLNA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Austin, TX

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1069530

Former names

CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC

Frequently asked questions